USE OF THE EXTRACELLULAR DOMAIN OF TRANSFERRIN RECEPTOR 2 FOR THE DIAGNOSTICS AND TREATMENT OF PRIMARY AND SECONDARY SCLEROSCLEROSING DISEASES

DE502017017164D1Active Publication Date: 2025-12-24KYMBA LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502017017164
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Filing Date
2017-06-14
Publication Date
2025-12-24
Estimated Expiration
2037-06-14
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.